Literature DB >> 10904793

Betahistine effects on cochlear blood flow: from the laboratory to the clinic.

E Laurikainen1, J F Miller, I Pyykkö.   

Abstract

The development of laser Doppler flowmetry techniques has contributed greatly to the study of cochlear blood flow (CBF). In animal models, intravenous betahistine dihydrochloride clearly increased CBF in a dose-dependent manner. This effect was greater in the cochlear vasculature than in the systemic vascular bed. The effects of betahistine were blocked by the alpha 2-antagonist idazoxan, thus suggesting an interaction between histaminergic and presynaptic adrenergic receptors. This was further supported by studies investigating the effects of electrical stimulation on CBF. Local (round window membrane) application of betahistine did not affect CBF, but had a non-specific effect on cochlear electrophysiology. This indicates that the receptors for betahistine vascular effects in the inner ear are most likely located in the modiolar artery. More recently, laser Doppler flowmetry techniques have been applied to human subjects. It has been shown that intratympanic application of adrenaline affects CBF and that this blood flow is under vigorous sympathetic control. Electrical stimulation has also been used to obtain measures of dynamic responsiveness in human subjects. This results in an increase in CBF, which is dependent on the intensity of the stimulation. Preliminary evidence indicates that this procedure can provide a standardized measure of the dynamic properties of CBF and may provide a means to differentially identify patients with compromised vasculature.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10904793     DOI: 10.1080/000164800750044407

Source DB:  PubMed          Journal:  Acta Otolaryngol Suppl        ISSN: 0365-5237


  5 in total

1.  Benign paroxysmal positional vertigo: a study of two manoeuvres with and without betahistine.

Authors:  M Cavaliere; G Mottola; M Iemma
Journal:  Acta Otorhinolaryngol Ital       Date:  2005-04       Impact factor: 2.124

2.  Effect of standard-dose Betahistine on endolymphatic hydrops: an MRI pilot study.

Authors:  R Gürkov; W Flatz; D Keeser; M Strupp; B Ertl-Wagner; E Krause
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-04       Impact factor: 2.503

Review 3.  Evidence and evidence gaps of medical treatment of non-tumorous diseases of the head and neck.

Authors:  Murat Bas
Journal:  GMS Curr Top Otorhinolaryngol Head Neck Surg       Date:  2016-12-15

4.  Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience.

Authors:  D Monzani; M R Barillari; M Alicandri Ciufelli; E Aggazzotti Cavazza; V Neri; L Presutti; E Genovese
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-12       Impact factor: 2.124

5.  Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo.

Authors:  Fritz Ihler; Mattis Bertlich; Kariem Sharaf; Sebastian Strieth; Michael Strupp; Martin Canis
Journal:  PLoS One       Date:  2012-06-20       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.